Alexander Fosså

6.8k total citations
101 papers, 2.1k citations indexed

About

Alexander Fosså is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexander Fosså has authored 101 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pathology and Forensic Medicine, 47 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander Fosså's work include Lymphoma Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (21 papers) and Viral-associated cancers and disorders (15 papers). Alexander Fosså is often cited by papers focused on Lymphoma Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (21 papers) and Viral-associated cancers and disorders (15 papers). Alexander Fosså collaborates with scholars based in Norway, Denmark and Germany. Alexander Fosså's co-authors include Sophie D. Fosså, Harald Holte, Cecilie E. Kiserud, Andreas Beyer, W H Kunau, Gustav Gaudernack, Torgeir Wethal, J. Kalervo Hiltunen, Ralf Erdmann and Thor Edvardsen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alexander Fosså

93 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Fosså Norway	25	813	585	401	381	338	101	2.1k
Doojduen Villaluna United States	18	350 0.4×	660 1.1×	357 0.9×	245 0.6×	529 1.6×	42	2.0k
Catherine Diefenbach United States	25	957 1.2×	1.1k 1.8×	520 1.3×	206 0.5×	142 0.4×	160	2.2k
F. Ries Luxembourg	21	323 0.4×	622 1.1×	330 0.8×	199 0.5×	325 1.0×	70	1.7k
Alberto Cauli Italy	31	322 0.4×	177 0.3×	272 0.7×	222 0.6×	160 0.5×	152	2.9k
Thomas Elter Germany	27	1.1k 1.4×	820 1.4×	185 0.5×	276 0.7×	395 1.2×	68	2.4k
Adam J. Olszewski United States	28	1.3k 1.6×	1.3k 2.3×	539 1.3×	796 2.1×	246 0.7×	212	3.1k
W. David J. Ryder United Kingdom	30	381 0.5×	1.3k 2.3×	623 1.6×	151 0.4×	995 2.9×	64	3.1k
Paolo Indolfi Italy	28	277 0.3×	412 0.7×	652 1.6×	347 0.9×	691 2.0×	92	2.1k
Jeong Eun Kim South Korea	25	464 0.6×	1.2k 2.0×	351 0.9×	101 0.3×	530 1.6×	176	2.2k
Toru Nakanishi Japan	34	585 0.7×	682 1.2×	1.1k 2.6×	138 0.4×	695 2.1×	148	4.3k

Countries citing papers authored by Alexander Fosså

Since Specialization

Citations

This map shows the geographic impact of Alexander Fosså's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Fosså with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Fosså more than expected).

Fields of papers citing papers by Alexander Fosså

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Fosså. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Fosså. The network helps show where Alexander Fosså may publish in the future.

Co-authorship network of co-authors of Alexander Fosså

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Fosså. A scholar is included among the top collaborators of Alexander Fosså based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Fosså. Alexander Fosså is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fosså, Alexander, Daniel Molin, Paul J. Bröckelmann, et al.. (2025). Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial. HemaSphere. 9(3). e70099–e70099. 1 indexed citations

Bröckelmann, Paul J., Boris Böll, Daniël G. M. Molin, et al.. (2024). Brentuximab Vedotin, Cyclophosphamide, Doxorubicin and Prednisone (B-CAP) First-Line Treatment of Advanced-Stage Hodgkin Lymphoma: Final Results of the GHSG-NLG Phase II Bvb Trial. Blood. 144(Supplement 1). 3054–3054.

Fluge, Øystein, et al.. (2023). Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study. Haematologica. 109(5). 1403–1412. 2 indexed citations

Luminari, Stefano, Alexander Fosså, Judith Trotman, et al.. (2023). Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial. Journal of Clinical Oncology. 42(1). 13–18. 16 indexed citations

Fosså, Alexander, Muhıt Özcan, Yuqin Song, et al.. (2023). WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). Hematological Oncology. 41(S2). 208–209. 1 indexed citations

Fosså, Alexander, et al.. (2023). Long‐term impact of gastropexy on use of acid‐reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy. Clinical Obesity. 13(5). e12618–e12618. 1 indexed citations

Fosså, Sophie D., Hege Sagstuen Haugnes, Alv A. Dahl, et al.. (2023). Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective. Annals of Oncology. 34(12). 1165–1174. 6 indexed citations

Oldervoll, Line, Alexander Fosså, Cecilie E. Kiserud, et al.. (2023). The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue. Supportive Care in Cancer. 32(1). 22–22. 3 indexed citations

Smeland, Knut B., et al.. (2023). Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma. Leukemia & lymphoma. 64(6). 1139–1150.

10.

Weibull, Caroline E., Karin E. Smedby, Lasse Jakobsen, et al.. (2023). Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study. International Journal of Cancer. 153(4). 723–731. 4 indexed citations

11.

Hoel, Fredrik, Ina K. N. Pettersen, Ingrid G. Rekeland, et al.. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 6(16). 34 indexed citations

12.

Holte, Harald, Ingrid Glimelius, Magnus Björkholm, et al.. (2019). No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. British Journal of Haematology. 188(5). 685–691. 18 indexed citations

13.

Fosså, Alexander, Helen Goergen, Peter Kamper, et al.. (2018). B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG). Kölner Universitäts PublikationsServer (Universität zu Köln).

14.

Pulczynski, Elisa Jacobsen, Outi Kuittinen, Martin Erlanson, et al.. (2014). Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group. Haematologica. 100(4). 534–540. 79 indexed citations

15.

Kiserud, Cecilie E., Harald Holte, Alexander Fosså, et al.. (2014). Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism. Acta Oncologica. 54(1). 49–59. 14 indexed citations

16.

Gjesdal, Ola, Torgeir Wethal, Kristina H. Haugaa, et al.. (2011). Left Ventricular Function Assessed by Two-Dimensional Speckle Tracking Echocardiography in Long-Term Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy With or Without Anthracycline Therapy. The American Journal of Cardiology. 107(3). 472–477. 82 indexed citations

17.

Alsøe, Lene, John E. Stacy, Alexander Fosså, et al.. (2007). Identification of prostate cancer antigens by automated high-throughput filter immunoscreening. Journal of Immunological Methods. 330(1-2). 12–23. 12 indexed citations

18.

Fosså, Alexander, Wolfgang Lilleby, Sophie D. Fosså, et al.. (2002). Independent prognostic significance of HER‐2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy. International Journal of Cancer. 99(1). 100–105. 38 indexed citations

19.

Fosså, Alexander, Reiner Siebert, Gunhild M. Mælandsmo, et al.. (2000). Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. British Journal of Cancer. 83(6). 743–749. 28 indexed citations

20.

Siebert, Reiner, Christoph Willers, Alexander Fosså, et al.. (1996). Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines. Leukemia Research. 20(2). 197–200. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact